Physician

David Pratt, MD

According to 2025 Medicare claims, David Pratt, MD (NPI: 1851492003) practices radiation oncology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is REVERE HEALTH PC (NPI: 1093764805; TIN: 870281028) and primary practice location at 84604-3305. Pratt is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), Aledade 201 National MSSP (ACO ID: A5522), and Revere Health Collaborative Network, LLC (ACO ID: D0042), participating under both the MSSP and REACH models.

Pratt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 155 traditional Medicare patients, billed 4,598 HCPCS/CPT codes, and received $702,388 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 79 prescription claims across 41 beneficiaries totaling $4,765 in drug costs. 2023 DME data shows 12 claims. Open Payments data shows 7 records totaling $232. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $624,923 and ending at $702,388. Concurrently, Part D prescription costs have fallen sharply in recent years, from $7,536 to $4,765. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	353	4,411	$624,923
2016	334	3,776	$637,201
2017	360	3,073	$498,763
2018	402	7,664	$695,887
2019	351	6,269	$733,546
2020	290	3,139	$632,240
2021	262	2,987	$569,929
2022	182	2,099	$371,402
2023	112	2,600	$378,163
2024	155	4,598	$702,388

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	88	213	$7,536
2016	85	218	$10,736
2017	75	181	$10,650
2018	67	181	$9,581
2019	76	167	$9,146
2020	63	118	$6,162
2021	60	116	$5,299
2022	45	86	$3,313
2023	29	57	$2,423
2024	41	79	$4,765

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	24	$1,680
2023	N/R	12	$2,173
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	64	80	$91
G6017	Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment	63	649	$89
77014	Ct guidance for insertion of radiation therapy fields	64	644	$88
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	96	122	$12
77417	X-ray during radiation therapy	54	130	$11

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$232	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Pratt, MD?

Tedicare shows public-source Medicare data for David Pratt, MD (NPI 1851492003), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Pratt, MD have ACO affiliation data?

David Pratt, MD is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215), Aledade 201 National MSSP (MSSP, ACO ID A5522), and Revere Health Collaborative Network, LLC (REACH, ACO ID D0042).

What billing organization is linked to David Pratt, MD?

David Pratt, MD is linked to REVERE HEALTH PC (billing NPI 1093764805) in the available physician profile data.

Does David Pratt, MD have Open Payments data?

David Pratt, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.